NCT01545310View on ClinicalTrials.gov

A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Schizophrenia
Interventions
DRUG

SLV354

One dose of ABT-354

Trial Locations (1)

06520-8048

Site Reference ID/Investigator# 52162, New Haven

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT01545310 - A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia | Biotech Hunter | Biotech Hunter